Loading…
Loading…
EQUITY / NASDAQ · XNCM
EUDA Health Holdings Limited
No accepted understanding yet. Follow this company to establish research where evidence supports it.
Open research workspace →01/01/2025 – 12/31/2025 · USD · Units
Reported figures establish facts for this period; they do not by themselves establish a profitability trend.
Open report ↗17.2363 USD
Observed: 10/02/2026 · tickerlayer · Historical end-of-day close
Powered by TickerLayer
10/02/2026 · 17.2363 USD · Volume 15,528
251 actual observations · Latest bar: 2026-10-02 · Market data is indicative; provider terms apply.
4 available financial reports
Research reports →SEC FINANCIAL REPORTS
01/01/2025 – 12/31/2025 · Units
| Metric | 2025 / Year end | 2024 / Year end | Change |
|---|---|---|---|
| Revenue | 6,820,264 USD | 4,011,005 USD | +70.04% |
| Operating profit | -2,477,992 USD | -17,335,131 USD | — |
| Net income | -2,772,762 USD | -15,357,156 USD | — |
| Operating cash flow | -2,426,535 USD | -2,034,727 USD | — |
| Total liabilities | 5,984,084 USD | 4,269,878 USD | +40.15% |
Changes are calculated only for matching period length, consolidation, currency, and scale. Percentages are not shown for zero or negative baselines.
Each column uses its report's scale. Check column headers before comparing different consolidation scopes and scales.
| Financial metric | 2025 / Year end01/01/2025 – 12/31/2025ConsolidatedUnits · USD | 2024 / Year end01/01/2024 – 12/31/2024ConsolidatedUnits · USD | 2023 / Year end01/01/2023 – 12/31/2023ConsolidatedUnits · USD | 2023 / Quarter 101/01/2023 – 03/31/2023ConsolidatedUnits · USD |
|---|---|---|---|---|
| Capital expendituresCash flow statement | 77,264 USD | 96,762 USD | — | — |
| Financing cash flowCash flow statement | 2,550,031 USD | 2,324,199 USD | 2,352,495 USD | 525,328 USD |
| Gross profitIncome statement | 2,992,799 USD | 762,155 USD | 842,075 USD | 403,598 USD |
| Investing cash flowCash flow statement | -104,450 USD | -147,766 USD | — | — |
| Net incomeIncome statement | -2,772,762 USD | -15,357,156 USD | -10,039,481 USD | -2,414,645 USD |
| Operating cash flowCash flow statement | -2,426,535 USD | -2,034,727 USD | -2,917,895 USD | -469,908 USD |
| Operating profitIncome statement | -2,477,992 USD | -17,335,131 USD | -3,961,054 USD | -1,976,780 USD |
| RevenueIncome statement | 6,820,264 USD | 4,011,005 USD | 3,706,458 USD | 1,698,734 USD |
| Total assetsBalance sheet | 1,716,562 USD | 1,697,810 USD | — | 25,478,778 USD |
| Total equityBalance sheet | -4,254,945 USD | -2,553,059 USD | -7,481,936 USD | -5,953,573 USD |
| Total liabilitiesBalance sheet | 5,984,084 USD | 4,269,878 USD | — | 31,417,343 USD |
| Cash and cash equivalentsBalance sheet | — | — | — | 837,292 USD |
| Report source | Open report ↗ Published: 04/28/2026 | Open report ↗ Published: 09/24/2025 | Open report ↗ Published: 04/28/2026 | Open report ↗ Published: 07/31/2023 |
The latest available source version is shown for each period. Previous versions and correction relationships are not shown in this view.